Download Saw palmetto

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Discovery and development of neuraminidase inhibitors wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Discovery and development of ACE inhibitors wikipedia , lookup

Discovery and development of proton pump inhibitors wikipedia , lookup

Hyaluronic acid wikipedia , lookup

Discovery and development of antiandrogens wikipedia , lookup

Transcript
Saw palmetto
BOTANY
Serenoa serrulata (Michx) G. NIcholson (=Sabal serrulata Rohm. & Schult.; Serenoa repens (Bartram)
Small.). This plant is a palm-tree belonging to the Arecaceae (formerly Palmaceae) family. Spanish
common names are sabal, palmera de Florida or palma enana americana; English common name is saw
palmetto. This tufted palm has creeping branching stems, which are 1-3m long and give the plant a
shrub-like appearance.
The leaves are bright-green and palmatisect (fan-shaped); they are borne on long petioles, which are
edged with spines. The flowers are small, clustered in panicles. The flowering season is from February
V 04-02/13
43561,46250,46260-1
Exclusive N.A. Distributor
CENTERCHEM, INC. NORWALK, CT
Ph: 203-822-9800 Fax: 203-822-9820
www.centerchem.com
to April. The fruits are globose drupes (2-3 X 1.5 cm), 1-seeded, rough to the touch and bluish-black
when ripe. In the northern hemisphere, these fruits are harvested from September to January.
Saw palmetto is native to the southeast area of the United States and the coastal plains of Florida and
Texas. It spreads throughout South Carolina and Louisiana. These plants grow on sandy marsh soils.
Saw palmetto extract is produced from the fruits of Serenoa serrulata.
CHEMISTRY
Carbohydrates
Inverted sugar (28.2%), mannitol, starch and high molecular-weight polysaccharides (500,000 and
higher) mainly galactose, arabinose, xylose, mannose, rhamnose, glucose and uronic acid.
Flavonoids
Saw palmetto fruits contain the following flavonoids: rutin, isoquercitrin, kaempferol 3-O-glucoside,
apigenin 7-O-rhamnoglucoside and anthranilic acid.
Phytosterols
β-sitosterol, stigmasterol, lupeol, campesterol and cycloartenol.
Fig.1. Structure of stigmasterol.
Fatty compounds
The main compound groups in saw palmetto fruits are: free fatty acids and their corresponding ethyl- and
methyl-esters, triglycerides, fatty alcohols, phytosterols, carotenoids and some triterpenes. Two
monoglycerides: 1-monolaurin and 1-monomyristin, have also been isolated.
V 04-02/13
43561,46250,46260-2
Fatty acids
Main fatty acids (C6 to C18) in saw palmetto fruits are: oleic, lauric, myristic, linoleic and linolenic acids.
Also, small amounts of palmitic, caprylic and capric acid have been found.
Ethyl-esters
The characteristic aroma of the oil is due to the presence of ethyl-esters of fatty acids, ethyl laureate
being the most abundant one.
Fatty alcohols
Saturated and unsaturated long-chain alcohols, including farnesol, phytol, alcohols with C22, C23, C24,
C26, C28 chains and polyprenoid alcohols.
Carotenoids
Carotenoids give saw palmetto oily extracts their marked orange coloration.
Table 1 shows the main components in saw palmetto fruits and their corresponding proportions.
Constituent
Content (%)
Constituent
Content (%)
Caprylic acid (C8:0)
1.3
Linoleic acid (C18:2)
3.6
Capric acid (C10:0)
1.8
Linolenic acid (C18:3)
0.7
Lauric acid (C12:0)
24.0
Campesterol
0.063
Myristic acid (C14:0)
11.6
Stigmasterol
0.024
Palmitic acid (C16:0)
8.7
Β-sitosterol
0.21
Stearic acid (C18:0)
1.4
Hexacosanol
0.018
Oleic acid (C18:1)
33.2
1-Octacosanol
0.19
Table 1. Fatty acids, alcohols and sterols identified in S. repens fruits extract under supercritical CO2 conditions (Bombardelli, E, &
Morazzoni, P., 1997).
Other active principles
Besides their high lipid proportion, the fruits also contain other constituents such as tannins, amino acids,
essential oil and resin.
V 04-02/13
43561,46250,46260-3
TRADITIONAL USES
Saw palmetto fruits have been an important
source of food and medicine for Native
American populations. References indicate
that Indian populations living in the south of
the United States and Florida, used saw
palmetto as an anti-inflammatory agent for
the urinary tract and as a sedative tonic.
Saw palmetto was popularly used as a
treatment for testicular atrophy, impotence,
male loss of libido and as a general tonic.
Other
traditional
treatment
of
enlargement,
applications
female
relief
of
include:
infertility,
menstrual
breast
pain,
Fig.2. Panoramic view of South Florida forests, one of the natural
habitats of saw palmetto.
appetite stimulation, tonic and expectorant,
especially used in bronchial conditions.
Present day therapeutic relevance of saw palmetto is based on the use of the liposterolic extract to treat
prostatic benign hyperplasia.
Furthermore, preparations including saw palmetto fruits extract are claimed to be effective treatments for
seborrhoea, acne and hair loss.
COSMETIC PROPERTIES
Moisturizing and filmogenic activity
Saw palmetto is rich in sugar and high molecular weight polysaccharides, hygroscopic substances
capable of absorbing and retaining water under certain conditions. Because of their large size,
polysaccharides remain on the surface of the stratum corneum, thus acting as moisturizing and
filmogenic substances, which noticeably improve skin biomechanical properties.
Moisturizing agents are compounds, which contribute to maintain the skin water-balance. Moisturizers
contribute flexibility to the stratum corneum; they facilitate desquamation through their action on
corneodesmosomes and affect the lipids, which exert the barrier function.
V 04-02/13
43561,46250,46260-4
Filmogenic agents are macromolecules, which remain on the stratum corneum surface, where they
retain water and improve the barrier function.
Therefore, saw palmetto is recommendable to formulate cosmetic products to improve skin moisture
levels.
Anti-inflammatory activity
Saw palmetto extract has a dual inhibitory effect on both
arachidonic acid metabolic pathways: the cyclooxygenase
pathway and the 5-lipooxygenase pathway. This action seems to
be unrelated to phospohlipase A2 inhibition. The acidic lipid
fraction of this extract inhibits the cyclooxygenase and 5lipooxygenase pathways to the same degree than the initial
extract. The fatty alcohol and the sterol fractions, as well as
beta-sitosterol, showed no inhibitory effect on either of these
pathways. Furthermore, the extract showed anti-edematous
effects on the vascular inflammation phase of in vivo
experimental models; these effects were due to histamine
inhibition (www.fitoterapia.net).
Oral administration of Serenoa repens extract showed antiedematous activity in several rodent models:
dextran-induced generalized edema in rats, centrifugation-induced tail edema in mice, histamine- and
dextran-induced capillary permeability in rats, IgE-dependent passive cutaneous anaphylaxis in rats,
and UV-induced erythema in guinea pigs. Since the antiedematous effects were also observed in
adrenalectomized rats, the involvement of glucocorticoids was ruled out. Saw palmetto extract seems to
act during the early phase of the inflammatory process by reducing microvascular permeability and
vascular stasis (Bombardelli, E. & Morazzoni, P., 1997).
Thus, saw palmetto extract is of great use to formulate cosmetic products with anti-irritant activity.
Antiandrogenic activity
Saw palmetto extract inhibits both 5-α-reductase isozymes. The enzyme 5-α-reductase allows for the
conversion of testosterone into dihydrotestosterone (DHT), an active androgen, which acts on the
proliferation of prostate cells (both in epithelium and stroma) in a dose-dependent and non-competitive
way. Saw palmetto inhibition is mainly due to the saponifiable fraction (lauric, linoleic and myristic acids).
The unsaponifiable fraction – which consists mainly of phytosterols – produces mild 5-α-reductase
inhibition. This extract reduces testosterone and DHT binding to the tissues. It competitively impairs DHT
binding to the cytoplasmic androgenic receptors in prostatic cells. This action is weaker on nuclear
V 04-02/13
43561,46250,46260-5
receptors than on cytosolic ones. Furthermore, a comparison before and after a treatment with the lipid
extract did not reveal plasmatic changes in the levels of testosterone, follicle stimulant hormone or
luteinizing hormone (www.fitoterapia.net).
Androgens directly influence the hair growth. It is known that 5-α-reductase activity – involved in
testosterone conversion to DHT – occurs in the cutaneous tissue. DHT is a highly active metabolite,
whose concentration is highest in the sebaceous gland and hair follicle area. Like other highly active
molecules, DHT is enzymatically metabolized to androstanediol. Two androstanediol isomers exist: one
inactive (end of the testosterone hormonal activity) and one active, 5-αandrostane 3β-17β-diol. It seems that active androstanediol acts selectively
on the ribosomes of the hair bulb matrix cells, inducing protein synthesis; it
also seems that DHT acts on the nucleus of matrix cells, inducing DNA
synthesis, thus eliciting mitosis. It can be accepted that the balance between
DHT and active androstanediol, which interact with their corresponding
follicular membrane receptors (bulb matrix and sebaceous gland cells), results
in a cell mitosis rate fitted to the synthesis rate of intracellular material: prekeratin in matrix cells and lipids in sebaceous cells (Pons Gimier, L., 1986).
Studies carried out on hairs extracted from alopecic and non alopecic scalp demonstrated high scalp
levels of 5-alfa-reductase and DHT in this type of alopecia.
Androgenic alopecia could be originated by a DHT-androstanediol imbalance. On the one hand,
excessive DHT stimulation would increase the mitosis rate; on the other hand, reduced androstanediol
stimulation would slow down protein synthesis in bulb matrix cells. The situation results in hair growth
cycles speeding-up and hair-shafts becoming thinner and thinner; more cell mitosis and less hair growth;
hyperplasia, which is not compensated by a corresponding hypertrophy (Pons Gimier, L., 1986).
Fig.3. Stepwise miniaturization of the hair follicle and shortening of the anagen growth phase, mediated by DHT, which result in
androgenic alopecia (Sinclair, R., 1998).
V 04-02/13
43561,46250,46260-6
Furthermore, increased DHT levels can be found in cases of seborrhoea, as revealed by the
comparison of acne-skin with normal skin (Pons Gimier, L., 1986).
A possible treatment for androgenic alopecia consists in topical hormone applications, aimed at
balancing the DHT and active-androstanediol stimuli on germinative matrix cells. In this sense, antiandrogenic preparations are formulated (Pons Gimier, L., 1986).
Saw palmetto anti-androgenic effects were recently verified on castrated rats treated with oral 150300mg doses of this extract for 10 consecutive days. A double-blind, randomized, placebo-controlled
study demonstrated the benefit of administering a liposterolic extract to 23-64 years old patients with
mild or moderate androgenic alopecia, with 60% average efficacy (Alonso J. 2004).
The anti-androgenic activity makes saw palmetto extract useful to formulate cosmetic products to treat
androgenic alopecia and cosmetic products for greasy skin and hair.
COSMETIC APPLICATIONS
ACTION
ACTIVE
COSMETIC APPLICATION
Moisturizing and filmogenic
Carbohydrates
Moisturizing
Anti-inflammatory
Acidic lipid fraction
Anti-irritant
Antiandrogenic
Saponifiable fraction
Anti-hair loss
Greasy skin and hair
RECOMMENDED DOSE
The recommended dose is between 0.5% and 5%.
BIBLIOGRAPHY
Alonso, Jorge. Tratado de Fitofármacos y Nutracéuticos. Barcelona: Corpus, 2004, p: (633.8 ALO).
Anguera, A. et al. El extracto lipídico de sabal (Sabal serrulata) en el tratamiento de la hiperplasia
benigna de próstata. Revista de Fitoterapia, 2002; 2 (1): 5-18 (ref. 5202).
Batlle Edo, C. & De Conte Vila, O. Alopecias. Calvicie. Farmacia Profesional, 1996; p: 32-46 (ref.
1740).
V 04-02/13
43561,46250,46260-7
Bombardelli, E. & Morazzoni, P. Serenoa repens (Bartram) J.K. Small. Fitoterapia, 1997; 68 (2): 99-113
(ref. 2309).
Bruneton J. Farmacognosia. Zaragoza: Ed. Acribia, 2001; p: 163-164 (651*1 BRU).
Buck, AC. Is there a scientific basis for the therapeutic effects of Serenoa repens in benign prostatic
hyperplasaia? Mechanisms of action. J Urol., 2004; 172 (5 Pt 1): 1792-1799.
Cristoni, A. et al. Botanical derivatives for the prostate. Fitoterapia (suplemento), 2000; 71 (1): 71-78
(ref.4007).
Cristoni, A. el al. Chemical and pharmacological study on hypercritical CO 2 extracts of Serenoa repens
fruits. Fitoterapia, 1997; 68 (4): 355-358 (ref. 2386)
Di Silveiro, F. et al. Evidence that Serenoa repens extract displays an astrogenetic activity in prostatic
tissue of benign prostatic hypertrophy patients. Eur Urol., 1992; 21 (4): 309-314.
Foley, PA. Dermatology. BMJ, 2000; 320: 850-853.
Guzmán Llansà, E. Alteraciones capilares. Caspa, cabellos grasos y cabellos secos. OFFARM, 1991; 1
(10): 99-106 (ref. 2445).
Lowe, FC & Fagelman, E. Phytotherapy in the treatment of benign prostatic hyperplasia. Curr Opin Urol,
2002, 12: 15-18.
Pons Gimier, L. Perder el cabello. Alopecia y ciclos capilares. OFFARM., 1986; 5 (11): 46-49 (ref. 1506).
Serra Llobet, J. Tratamiento de las alopecias. El Farmacéutico, 2001; 271: 42-57 (ref. 4826).
Sinclair, R. Male pattern androgenetic alopecia. BMJ, 1998; 317: 865-869.
Web stites:
www.fitoterapia.net [consulted January 2006].
V 04-02/13
43561,46250,46260-8